Sino Medical Sciences Technology Inc. (SHA:688108)
31.41
+0.71 (2.31%)
Sep 12, 2025, 3:00 PM CST
SHA:688108 Revenue
Sino Medical Sciences Technology had revenue of 139.63M CNY in the quarter ending June 30, 2025, with 13.86% growth. This brings the company's revenue in the last twelve months to 485.52M, up 22.71% year-over-year. In the year 2024, Sino Medical Sciences Technology had annual revenue of 458.74M with 33.64% growth.
Revenue (ttm)
485.52M
Revenue Growth
+22.71%
P/S Ratio
26.92
Revenue / Employee
4.30M
Employees
691
Market Cap
13.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 458.74M | 115.48M | 33.64% |
Dec 31, 2023 | 343.26M | 150.40M | 77.99% |
Dec 31, 2022 | 192.85M | -1.50M | -0.77% |
Dec 31, 2021 | 194.36M | -133.06M | -40.64% |
Dec 31, 2020 | 327.42M | -108.49M | -24.89% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |